RetinalGenix Technologies (RTGN) Debt to Equity (2021 - 2025)
RetinalGenix Technologies' (RTGN) quarterly Debt to Equity came in at -$0.02 in Q4 2025, up 36.48% year-on-year from -$0.02 in Q4 2024, and up 5.64% quarter-over-quarter from -$0.02 in Q3 2025.
RetinalGenix Technologies (RTGN) Debt to Equity (2021 - 2025) Analysis & Trends
RetinalGenix Technologies has disclosed Debt to Equity across 5 years of filings, most recently posting -$0.02 for Q4 2025.
- Debt to Equity for Q4 2025 came in at -$0.02, up 36.48% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.02 (up 36.48% YoY), and the FY2025 annual result was -$0.02, up 36.48% from the prior year.
- Debt to Equity came in at -$0.02 for Q4 2025 at RetinalGenix Technologies, up from -$0.02 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.02 in Q4 2025 to a low of -$0.4 in Q3 2021.
- The 5-year median for Debt to Equity is -$0.03 (2023), against an average of -$0.07.
- Across the five-year window, Debt to Equity jumped 88.61% in 2022 and gained 1.15% in 2024, its largest moves.
- RetinalGenix Technologies' Debt to Equity stood at -$0.16 in 2021, then soared by 70.82% to -$0.05 in 2022, then advanced by 23.95% to -$0.03 in 2023, then gained by 3.89% to -$0.03 in 2024, then soared by 36.48% to -$0.02 in 2025.
- The last three Debt to Equity figures came in at -$0.02 (Q4 2025), -$0.02 (Q3 2025), and -$0.02 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.06 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.95 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.71 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 0.27 |
| 10 | RetinalGenix Technologies | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.03 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.40 |